SIU Academy is a digital learning resource for urologists
Enter the portal

SIU Academy Governance Committee

Kurt McCammon

Kurt McCammon

MD, FACS - United States

Dr. McCammon earned his medical degree, magna cum laude, from the Medical College of Ohio in Toledo, OH, in 1992 after completing his undergraduate degree in Biology at the University of Toledo in 1988. He served his internship in general surgery in the Department of Surgery at Eastern Virginia Graduate School of Medicine, where he also completed his residencies in general surgery and urology, receiving the Upjohn Award for Intern of the Year in 1993 and Eunice Baxter award for Chief Resident of the Year in 1997.  He completed a Fellowship in Adult and Pediatric Genitourinary Reconstructive Surgery at Eastern Virginia Medical School in 1998.

Dr. McCammon’s practice is limited almost exclusively to adult and pediatric genitourinary reconstructive surgery.  Board certified in Urology, he is a Fellow of the American College of Surgeons.  Dr. McCammon serves as Professor of Urology at Eastern Virginia Medical School and currently serves as the Chairman and Program Director of the Department of Urology and is the Director of the Adult and Pediatric Genitourinary Reconstructive Fellowship Program at the Eastern Virginia Medical School.  He was honored to be named the Devine Chair in Genitourinary Reconstructive Surgery in 2013.  He has wide and varied academic interests and is an innovative leader in the field of genitourinary reconstructive surgery.  He is keenly motivated in the area of investigation and has made notable contributions to Urologic literature.  Dr. McCammon also participates in numerous national and international medical conferences and serves as a visiting professor at many centers throughout the world.

Stavros Gravas

Stavros Gravas

MD, PHD, FEBU - Greece

Dr. Stavros Gravas became a qualified urologist in 1999 and was also qualified as Fellow of the European Board of Urology (FEBU) in the same year. In 2002, he attended the 12-month fellowship on Endourology (by the Endourological Society) at Minimal Invasive Urology Centre and Laparoscopy of the University Hospital in Nijmegen. In 2005, he received his doctorate degree from the University of Athens, and in 2007 his Ph.D. thesis entitled “Transurethral Microwave Thermotherapy for BPH – From Evidence-based Guidelines to Clinical Practice” from the University of Amsterdam. 

Dr. Gravas is the chairman of the European Association of Urology (EAU) Guidelines Working Group on BPH/male LUTS/BOO. He was member of the Committee on New Minimally Invasive and Surgical Developments in the management of Benign Prostatic Obstruction of the International Consultation on Prostate Diseases. Other working group memberships include the Editorial Board at Large of European Urology and European Urology Supplements, the Editorial Board of Journal of Endourology (serving as Section Editor on New Technologies). 

Dr. Gravas is a member of the Council of the Clinical Research Office of the Endourological Society (CROES) representing Europe and he served as member of the Board of the Directors of the Endourological Society until 2012. He is a member of many national and international societies and reviewer in European Urology, Journal of Urology, Urology, British Journal of Urology International, Journal of Endourology, International Journal of Urology, Current Urology, Clinical Drug Investigation and Hellenic Urology. 

Dr. Gravas is Assistant Professor of Urology (University of Thessalia) and works at the Department of Urology of the University Hospital of Larissa. His main fields of interest include medical and minimally invasive therapies for BPH, endourology, and stone management.

Peter Black

Peter Black

MD, FACS, FRCSC - Canada

Coming soon

Osamu Ogawa

Osamu Ogawa

MD - Japan

Coming Soon

Peter Hammerer

Peter Hammerer

MD - Germany

Coming Soon

Reynaldo G. Gomez

Reynaldo G. Gomez

MD, FACS - Chile

Dr Reynaldo Gómez obtained his MD degree from the Catholic University of Chile School of Medicine in 1978. He then completed a residency program in general surgery and urology, obtaining a Master of Surgery degree and a Specialist in Urology degree in 1984 from the same school. He completed his training with a postdoctoral fellowship at the University of California, San Francisco School of Medicine, and the San Francisco General Hospital in 1991.

Dr Gómez started the Urology Service at the Hospital del Trabajador in Santiago, Chile, in 1984, and has been its chief since then. He was appointed associate professor of urology at the Andrés Bello University School of Medicine in 2011.

Dr Gómez is a member of many scientific societies and was president of the Chilean Society of Urology in 2001–2002. He has served on the Board of the Confederacion Americana de Urologia and was president of the Genitourinary Reconstructive Surgeons Society (GURS) in 2010. Dr Gómez is a reviewer on the editorial boards of the Chilean Journal of Surgery, the Chilean Journal of Urology, Urology (the Gold Journal), and the International Urology and Nephrology Journal.

Dr Gómez has been involved with the SIU since 2000, serving as the Chilean delegate from 2001 to 2010. He served in the SIU BOC from 2004 to 2011, as chairman of the Publications Committee and then as chair of the Internet and Telecommunications Committee. 

Faysal Yafi

Faysal Yafi

MD, FRCSC - United States

Dr. Yafi earned his medical degree from the American University of Beirut, Lebanon in 2005 after completing his undergraduate degree in Biology at the same institution in 2001. He then served his internship in General Surgery in the Department of Surgery at the American University of Beirut in 2006 before transferring to the Mayo Clinic in Rochester, Minnesota where he completed a year of preliminary surgery in the Department of Surgery in 2007. He subsequently completed a two-year research fellowship in the Biology and Therapy of Bladder Cancer in the Division of Urology at McGill University in Montreal, Canada in 2009. He subsequently completed his residency in Urology at McGill University in 2014, receiving the Division of Urology Outstanding Resident/Fellow Teacher of the Year Award in 2014. He is currently in the second year of his fellowship in Andrology at Tulane University, where he also serves as Clinical Instructor of Urology.

Dr. Yafi is a Fellow of the Royal College of Surgeons of Canada (Urology). He has previously served as chairman of the Northeastern Section of the AUA Residents Committee and member of the AUA Residents Committee. He is currently a member of the Sexual Medicine Society of North America Young Clinicians Committee. He has received multiple awards and recognitions, including the first prize essay contest of the Canadian Urological Association. Dr. Yafi has an avid interest in both basic and clinical research, with over 40 peer-reviewed publications and book chapters. His areas of focus include Peyronie’s disease, erectile dysfunction, androgen replacement therapy, prosthetic surgery (inflatable penile prosthesis and artificial urinary sphincter), male infertility, and urethral reconstruction.

Jack Zuckerman

Jack Zuckerman

MD - United States

Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed an internship in General Surgery at the Naval Medical Center in San Diego and then went on to complete Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He finished his training at EVMS with a fellowship in genitourinary reconstructive surgery.  He recently returned to California and is faculty at the Naval Medical Center in San Diego.

Dr. Zuckerman’s research interests are primarily focused on male reconstruction, including ongoing prospective randomized controlled trials, basic science animal models and large clinical databases.  While his focus is on urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology.

Committee for CME Programs

Stavros Gravas

Stavros Gravas

MD, PHD, FEBU - Greece

Dr. Stavros Gravas became a qualified urologist in 1999 and was also qualified as Fellow of the European Board of Urology (FEBU) in the same year. In 2002, he attended the 12-month fellowship on Endourology (by the Endourological Society) at Minimal Invasive Urology Centre and Laparoscopy of the University Hospital in Nijmegen. In 2005, he received his doctorate degree from the University of Athens, and in 2007 his Ph.D. thesis entitled “Transurethral Microwave Thermotherapy for BPH – From Evidence-based Guidelines to Clinical Practice” from the University of Amsterdam. 

Dr. Gravas is the chairman of the European Association of Urology (EAU) Guidelines Working Group on BPH/male LUTS/BOO. He was member of the Committee on New Minimally Invasive and Surgical Developments in the management of Benign Prostatic Obstruction of the International Consultation on Prostate Diseases. Other working group memberships include the Editorial Board at Large of European Urology and European Urology Supplements, the Editorial Board of Journal of Endourology (serving as Section Editor on New Technologies). 

Dr. Gravas is a member of the Council of the Clinical Research Office of the Endourological Society (CROES) representing Europe and he served as member of the Board of the Directors of the Endourological Society until 2012. He is a member of many national and international societies and reviewer in European Urology, Journal of Urology, Urology, British Journal of Urology International, Journal of Endourology, International Journal of Urology, Current Urology, Clinical Drug Investigation and Hellenic Urology. 

Dr. Gravas is Assistant Professor of Urology (University of Thessalia) and works at the Department of Urology of the University Hospital of Larissa. His main fields of interest include medical and minimally invasive therapies for BPH, endourology, and stone management.

Kurt McCammon

Kurt McCammon

MD, FACS - United States

Dr. McCammon earned his medical degree, magna cum laude, from the Medical College of Ohio in Toledo, OH, in 1992 after completing his undergraduate degree in Biology at the University of Toledo in 1988. He served his internship in general surgery in the Department of Surgery at Eastern Virginia Graduate School of Medicine, where he also completed his residencies in general surgery and urology, receiving the Upjohn Award for Intern of the Year in 1993 and Eunice Baxter award for Chief Resident of the Year in 1997.  He completed a Fellowship in Adult and Pediatric Genitourinary Reconstructive Surgery at Eastern Virginia Medical School in 1998.

Dr. McCammon’s practice is limited almost exclusively to adult and pediatric genitourinary reconstructive surgery.  Board certified in Urology, he is a Fellow of the American College of Surgeons.  Dr. McCammon serves as Professor of Urology at Eastern Virginia Medical School and currently serves as the Chairman and Program Director of the Department of Urology and is the Director of the Adult and Pediatric Genitourinary Reconstructive Fellowship Program at the Eastern Virginia Medical School.  He was honored to be named the Devine Chair in Genitourinary Reconstructive Surgery in 2013.  He has wide and varied academic interests and is an innovative leader in the field of genitourinary reconstructive surgery.  He is keenly motivated in the area of investigation and has made notable contributions to Urologic literature.  Dr. McCammon also participates in numerous national and international medical conferences and serves as a visiting professor at many centers throughout the world.

Simon Tanguay

Simon Tanguay

MD, FRCSC - Canada

Dr. Simon Tanguay completed his urology training at McGill University in 1992 and his fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center in 1995. 

He is currently a professor in the Department of Surgery (Division of Urology) at McGill University, and head of urologic oncology at the McGill University Health Centre. 

Dr. Tanguay was actively involved in the Quebec Urological Association, where he served as president of continuing medical education and treasurer. He also served as a member of the executive committee of the Genito-Urinary Group at the National Cancer Institute of Canada. He is currently a member of the Kidney Cancer of Canada Medical Advisory Board. 

Dr. Tanguay currently holds the position of general secretary of the Société Internationale d’Urologie.

Jean de la Rosette

Jean de la Rosette

MD, PhD - The Netherlands

Dr Jean de la Rosette received his medical degree from the University of Nijmegen, the Netherlands, in 1992. He was then appointed consultant urologist and director of Minimally Invasive Urology in the Department of Urology at the University Hospital at Nijmegen. He obtained his doctorate in 1994.

Since 2002, Jean de la Rosette has served as professor and chairman of the Department of Urology at the Academic Medical Centre (AMC) and University of Amsterdam, the Netherlands. Dr de la Rosette is a member of the Minimally Invasive Treatment of Benign Prostatic Hyperplasia (BPH) committee of the International Consultation on BPH, and chairman of the Renal Stone committee of the World Health Organisation (WHO). He has been appointed as chairman of the Clinical Research Office of the Endourological Society (CROES) and is a member of the society’s board.

Dr de la Rosette is a member of various urological societies, including the American Urological Association (AUA), the European Association of Urology (EAU), and the Endourological Society. He is also on the editorial board of the Journal of Endourology, European Urology, the Journal of Urology, BJU International, the Journal of Central Europe, and the Turkish Journal of Urology.

Dr de la Rosette is currently a member of the Executive Board of the Société International d’Urologie. 

Gerry Jordan

Gerry Jordan

MD - United States

Coming Soon

Jean McDonald

Jean McDonald

MB BS, FRCS(Ed), Dip Urol(Lond) - United Kingdom

Coming Soon

Serigne Gueye

Serigne Gueye

MD, FWACS - Senegal

Coming Soon

Sub-committees

Bladder and Upper Urinary Tract TCC


Mihir Desai

Mihir Desai

MD - United States

Dr. Mihir M. Desai is Professor of Urology and Director of the Center for Robotics at the University of Southern California (USC) Institute of Urology. He was previously Director of the Center of Endourology at the Cleveland Clinic. Dr Desai’s field of expertise includes robotic and laparoscopic oncology and new technologies.

Dr. Desai is an internationally renowned expert in the field of robotic oncologic surgery. He has made pioneering contributions in the fields of robotic radical cystectomy and intracorporeal urinary diversion. He has led the effort at USC to standardize a completely intracorporeal technique of urinary diversion, including orthotopic neobladder and ileal conduit procedures. He has also made significant innovations in robotic partial nephrectomy, robotic surgery for advanced renal cell carcinoma including caval thrombectomy and robotic surgery for high-risk prostate cancers.

Dr. Desai’s pioneering work in developing novel technology includes novel flexible robotic platforms, natural orifice surgery (NOTES) and single-port (scarless belly-button) laparoscopic surgery for various urologic conditions. He has won a total of 35 awards pertaining to his innovations and research including the prestigious Arthur Award conferred by the Endourologic Society in 2012, Endourology Society Essay Contest (2001-2003), and American Urological Association Video Awards (2001-2009). He has published over 200 manuscripts in peer-reviewed literature with an H-index of 37. 

Dr. Desai serves as associate editor of Urology and is currently a member of the editorial board of the Journal of Endourology. He is also co-editor of the recently launched Videourology section of the Journal of Endourology. Dr. Desai has been invited as visiting professor to many institutions and societies worldwide.

Ashish Kamat

Ashish Kamat

MD - United States

Dr. Ashish M. Kamat is an Associate Professor and Attending Surgeon in the Department of Urology/Division of Surgery at the MD Anderson Cancer Center in Houston, Texas. He is also the Director of the Urologic Oncology Fellowship Program at the same institute. 

Dr. Kamat is an internationally recognized expert in urologic oncology. He has a special interest in cancers of the bladder and prostate, with an emphasis on organ-sparing therapies, minimally invasive techniques (e.g., robotic surgery), and orthotopic bladder substitution (neobladder). While he is a busy, clinically active surgeon, he maintains an active research portfolio in order to improve the care for patients. In the clinical arena, in concert with efforts to develop novel therapies, Dr. Kamat’s efforts are directed toward identifying predictors of response to therapy, as a first step toward personalized cancer therapeutics. A major focus of his laboratory research is to develop novel therapies for bladder cancer using an approach which encompasses novel use of existing agents, the identification of novel targets and therapies, or a combination of these strategies.

Dr. Kamat has authored numerous editorials and more than 150 publications in prestigious peer-reviewed journals, and serves on the editorial board of Expert Reviews in Anticancer and F1000 Reviews. His basic, translational, and clinical research is funded by peer-reviewed awards including ones from the National Cancer Institute (NCI). He serves as project principal investigator (PI) on the MD Anderson Cancer Center GU (Bladder) SPORE (which stands for Specialized Programs of Research Excellence), which is the only one of its kind in the country. He has served as a member on the NCI Bladder Cancer task force and Grant Review Committees (such as NIH-RO1 study sections), and for various international societies (such as the Dutch Cancer Society and NIH—Singapore). 

Dr. Kamat is listed in ‘Who’s Who in Medicine’ and ‘Best Doctors in America,’ and has received the ‘Compassionate Doctor Award.’ He is active in many cancer support groups, such as the MD Anderson Bladder Support Group (for which he serves as Medical Director), as well as the Bladder WebCafe and Bladder Cancer Advocacy Network (BCAN). 

Dr. Kamat is an active member of the urologic community, and a graduate of the American Urological Association (AUA) Leadership Program. He serves on the Board of Directors for the South Central Section (SCS) of the AUA and is The State Representative (Texas) for Urology.

Theo de Reijke

Theo de Reijke

MD, PHD, FEBU - The Netherlands

Dr Theo M. de Reijke received his medical training at VU University Amsterdam, in the Netherlands, and has worked as a urologist at the Academic Medical Center in Amsterdam since 1987.

 In 2004, Dr de Reijke successfully defended his thesis on immunotherapy for bladder cancer. Throughout his career, he has authored more than 150 publications in peer-reviewed journals, and contributed to many book chapters. Uro-oncology is his main field of interest.

Dr de Reijke has been an active member of the European Organization for Research and Treatment of Cancer Genito-Urinary Group for many years, and was elected Secretary and later Chairman, serving until June 2009. In the Netherlands, he is Chairman of the Prostate Cancer Guideline Committee, and a member of the Bladder Cancer Guideline Committee. He has also served as Chairman of the Dutch Urologic Training Program for residents, and as a member of the European Board of Urology Examination Committee. Dr de Reijke is an honorary member of the Polish and Romanian Society of Urology, and was recently elected Visiting Professor for the medical school in Warsaw, Poland.

Michael Rink

Michael Rink

MD, FEBU - Germany

Michael Rink studied medicine at the University of Münster, Germany, and completed his residency at the Department of Urology at the University Medical Center Hamburg-Eppendorf, Germany, in 2012. From 2011 to 2012, Dr. Rink completed an uro-oncologic research fellowship at the Brady Urologic Center of the Weill Cornell Medical Center in New York City, New York, United States. His main scientific areas of interest comprise urothelial carcinoma of the upper and lower tracts, as well as prostate and renal cell cancers. In these fields, he combines research on basic, biologic, and prognostic markers with translational outcomes. He continued his academic career at the University Medical Center Hamburg-Eppendorf from 2013 as a fellow in urology and became an assistant professor in urology in March 2014.

Dr. Rink has conducted several clinical trials as principal investigator or sub-investigator. In addition, he has been involved in numerous clinical research studies and research projects. For his research, he has won several honours and awards. His research results are published in more than 90 peer-reviewed scientific papers, summaries, and book chapters. He currently serves as a reviewer for several urologic and oncologic journals and is a member of the Editorial Board of several highly respected journals.

Dr. Rink is a member of many national and international scientific societies. He currently sits on the advisory boards of several pharmaceutical companies, as well as on the boards of not-for-profit societies. He has been a member of the ICUD (International Consultation on Urological Diseases) for Upper Tract Urothelial Carcinoma since 2012.

 

Education in the Developing World


Ijeoma Chibuzo

Ijeoma Chibuzo

MD - Nigeria

Dr. Ijeoma N. C. Chibuzo is a resident in Urology at the University College Hospital (UCH), Ibadan, Nigeria, West Africa. She was the best resident in the nation in the 2014 Surgery pre – subspecialisation (Part I) examinations, for which she was received the prestigious Oritsejolomi Thomas award. Since she commenced training in Urology at UCH, an uncommon choice for females in her country, she has participated in national and international presentations at urological conferences and has won awards for best paper presentations. These include best paper presentations at the  3rd Symposium on Affordable New Technologies in Urology of the 34th SIU Congress, Glasgow, Scotland; and the Pan African Urological Surgeons' Association Conference held in Accra, Ghana, when she presented on behalf of her team members.

She has a Masters in Surgical Sciences in view. She has publications in peer – reviewed journals. She has participated in international exchange programs that have permitted exposure to variegated experiences and learning opportunities. She is currently working on two fellowship dissertations in urological oncology and urodynamics. She is also interested in renal transplantation and endourology.

Mohamed Jalloh

Mohamed Jalloh

MD - Senegal

Coming Soon

Rong Na

Rong Na

MD - China

Dr. Na is a urologist from Shanghai, China.  He finished his medical school at Fudan University, Shanghai Medical College, and got an MD degree in 2013. During his college period, he was able to study in Wake Forest University (USA) for research training. He took his internship and residency training at Huashan Hospital, Fudan University, Shanghai. His research interests are prostate cancer biomarkers, genetic research of urological diseases and precision medicine.  He enjoys swimming and hiking.

E. Oluwabunmi Olapade-Olaopa

E. Oluwabunmi Olapade-Olaopa

MD, MBBS, FRCS, FWACS - Nigeria

Emiola Oluwabunmi Olapade-Olaopa is a Professor in the Department of Surgery, College of Medicine, University of Ibadan and a Consultant Urologist at the University College Hospital, Ibadan, Nigeria.  A graduate of the University of Ibadan, he trained in general surgery and urology in the United Kingdom, and subsequently undertook Fellowship training in Urology at the University of Michigan Medical Center, Ann Arbor, Michigan. He is the Director of the PIUTA Ibadan Centre and of Urological Training at the University College Hospital, Ibadan, which is an SIU-accredited urological training centre.  His research interests are basic, clinical and public health sciences of urological oncology, as well as BPH and bladder disorders. He is well-published and cited in major scientific journals. He is the current President of the Pan-African Urological Association (PAUSA), and Program Chair of the African and Carribean Urological Associations Education Forum at the American Urological Association.

Satyendra Persaud

Satyendra Persaud

MD - Trinidad and Tobago

Dr. Persaud is a Guyanese by birth who completed his medical training at the University of Guyana in 2005. He did his internship and general surgery training at the Queen Elizabeth Hospital in Barbados. He completed his residency in Urology at the San Fernando General Hospital which is a University of the West Indies teaching hospital. It is also an SIU training facility. He also has served as Organizing Secretary of the Caribbean Urological Association for the past 3 years. He has an interest in uro-oncology, urolithiasis and reconstruction. He also enjoys cricket and fishing.

Shancheng Ren

Shancheng Ren

MD - China

Dr. Shancheng Ren is a Chinese army doctor who completed his medical training and got a phD degree at the Second Military Medical University in 2009. He was sponsored by China Scholarship Council to University of California, San Francisco and trained as joint PhD student from 2008 to 2010. He is now associate professor in Urology at Shanghai Changhai Hospital. His clinical interest is robotic-assisted radical prostatectomy and research interest is the early diagnosis biomarkers for prostate cancer. He enjoys traveling during his free time.

 

Endourology


Sero Andonian

Sero Andonian

MSC, MDCM, FRCS(C) - Canada

After obtaining his Bachelor of Science degree (First Class Honours, Dean’s Honour List) in Anatomy and Cell Biology at McGill University, Dr. Andonian pursued a Master of Science degree at the same university with his thesis entitled “Structure and function of the rat vas deferens”. Dr. Andonian obtained his MDCM degree from McGill University in 2002 and completed Urology residency training at McGill University Health Centre in 2007. In order to further develop his minimally invasive techniques, Dr. Andonian completed a two year Endourology fellowship at the prestigious North Shore-Long Island Jewish Health System, under the supervision of Dr. Louis Kavoussi and Dr. Arthur Smith.

 In July 2009, he was appointed Assistant Professor of Surgery (Urology) at McGill University and has been an Attending Urologist at the McGill University Health Centre. To further develop his pedagogical skills, Dr. Andonian completed Teaching Scholars Program for Educators in Health Sciences in 2011.

 Since his faculty appointment, Dr. Andonian has been active in clinical research, including: teaching minimally invasive procedures for treatment of kidney stones, assessing determinants of fluoroscopy usage during endourologic procedures, and determining whether training on simulators improves endourologic surgical outcomes. In addition to minimally invasive procedures and radiation safety, Dr. Andonian is involved in active clinical research regarding medical management of kidney stones. He has received research grants from the Quebec Urological Association, the Canadian Urological Association Scholarship Fund, the Northeastern AUA Young Investigator Award, and most recently he has been awarded the prestigious Chercheur Boursier Clinicien from Fonds de Recherche Santé Québec for the 2013-2017 period.

 He has published over 70 peer-reviewed manuscripts. In addition, he has authored nine book chapters including two chapters in the Smith’s Textbook of Endourology and the chapter on “Surgical, Radiological, and Endoscopic Anatomy of the Kidney and Ureter” in the 11th edition of Campbell-Walsh Urology. Furthermore, he has produced 11 educational videos in the field of endourology. Dr. Andonian has given plenary lectures and courses at several national and international meetings including the Canadian Urological Association (CUA), American Urological Association (AUA), and Société Internationale d’Urologie (SIU) Annual Meetings. He has won several prizes, including the Everett Reid Teaching Excellence Award in 2011 and the Best Laparoscopic Paper at the World Congress of Endourology in 2008. Recently, he has participated in both CUA’s guidelines on ureteral stones and the SIU’s International Consultation on Stone Disease. Currently, Dr. Andonian is on the CUA Executive Committee and editorial boards of Canadian Urological Association Journal and Videourology: Journal of Endourology.

Kristin Chrouser

Kristin Chrouser

MD, MPH - United States

Dr. Kristin Chrouser is an Assistant Professor in Urology at the University of Minnesota.  Her clinical interests involve stone disease and reconstruction of the urethra after damage by stricture disease or vesicovaginal fistulae (VVF).  Her research interests include maximizing intraoperative surgical quality and patient safety, optimization of surgeon performance, intraoperative teamwork, and vesico-vaginal fistula prevention. She is also dedicated to improving access to surgical care in low income countries through surgeon training.  She is a graduate of Princeton University (BA), Mayo Medical School (MD) and John Hopkins Bloomberg School of Public Health (MPH).

Bogdan Geavlete

Bogdan Geavlete

MD - Romania

Dr. Bogdan Geavlete, MD, PhD, is Associate Professor at the "Saint John" Emergency Clinical Hospital, Department of Urology in Bucharest, Romania. As a research scholar, his training included fellowships in endourology in general at Asklepios Klinik Barmbek in Hamburg, Germany, as well as in flexible ureteroscopy in particular, at Tenon Hospital in Paris, France. Dr. Geavlete also completed a European Urological Scholarship Programme (EUSP) clinical fellowship at Radboud University, in Nijmegen, The Netherlands.

During the past 10 years, he was involved as faculty (speaker and moderator) in the most prestigious urological international events such as the EAU, AUA, WCE, SIU, CEM, EULIS and Challenges in Endourology annual meetings, while also co-authoring over 300 posters and videos.  

His main areas of expertise and research focuses have been centered on non-muscle invasive bladder cancer (PhD in photodynamic diagnostic, international premiere and randomized clinical research in plasma-button large tumors’ vaporization), benign prostatic obstruction (prospective, randomized-controlled studies in BPH bipolar plasma enucleation published in famous ISI journals) and urolithiasis (international speaker, moderator and trainer in flexible ureteroscopy).

Dr. Geavlete gained 10 international awards for best posters, videos or oral presentations in the most important congresses of the urological international scientific agenda such as the EAU, CEM, EMUC, Experts in stone disease, Engineering and Urology Society and Challenges in Endourology & Functional Urology meetings. Also, he is an investigator in multicenter international clinical trials as well as in national research grants, while also completing a post-PhD research fellowship in narrow band imaging. He is a member in the organizing committees of national congresses and earned 5 national awards.

Over the past decade, Dr. Geavlete has been selected as a reviewer for 31 international journals, published 3 books in international publishing houses and 26 articles in international ISI journals and co-authored 68 PubMed indexed articles.

Sabnis Ravindra

Sabnis Ravindra

M.S., M.Ch. (Urology) - India

Coming Soon

 

Infertility and Men's Health


Martin Kathrins

Martin Kathrins

MD - United States

Dr. Kathrins is a male infertility and andrology specialist with interests in the treatment of men with azoospermia, advances in hormone replacement therapy, and medical device innovation. He completed undergraduate studies in biology at the University of Pennsylvania and medical school at Columbia University College of Physicians and Surgeons. He completed a surgical internship and urology residency at the University of Pennsylvania in 2014. He subsequently pursued fellowship training in male infertility and andrology at the University of Illinois at Chicago with Craig Niederberger, MD. He is currently a faculty member in the Division of Urology at Brigham and Women's Hospital in Boston, Massachusetts. 

 

 

Jim Hotaling

Jim Hotaling

MD, MS, FECSM - United States

Dr. Hotaling has significant training in both the clinical aspects of male fertility and genetic epidemiology and he is currently the only fellowship trained male infertility/andrology expert in Utah. He completed a 6 year residency in urology at the University of Washington, elected to pursue a year of sub-specialty training in male infertility with Craig Niederberger at The University of Illinois Chicago and has a long term research goal of developing novel genetic markers for male infertility that can be used clinically to diagnose and treat this devastating condition.

He has seen and performed surgery on hundreds of men with male infertility and is an associate editor of Fertility and Sterility, a premier journal in the field has had significant extramural research funding and has over 25 publications. He obtained an MS in clinical epidemiology in 2010 with a focus on statistical genetics and conducted the first genetic study on erectile dysfunction at the University of Washington.

Prior work building the male fertility cryopreservation databank at The University of Washington resulted in his creation of the largest U.S. database of men cryopreserving sperm for cancer. While at The University of Illinois Chicago, he initiated studies on the genetics of male infertility. As part of this collaboration, he established a protocol for the collection and banking of DNA and serum and linkage to a de-identified database, gMR, an infertility specific electronic medical record. gMR allows uniform phenotyping and is going to be used by several members of a CDC working group for research collaboration.

Faysal Yafi

Faysal Yafi

MD, FRCSC - United States

Dr. Yafi earned his medical degree from the American University of Beirut, Lebanon in 2005 after completing his undergraduate degree in Biology at the same institution in 2001. He then served his internship in General Surgery in the Department of Surgery at the American University of Beirut in 2006 before transferring to the Mayo Clinic in Rochester, Minnesota where he completed a year of preliminary surgery in the Department of Surgery in 2007. He subsequently completed a two-year research fellowship in the Biology and Therapy of Bladder Cancer in the Division of Urology at McGill University in Montreal, Canada in 2009. He subsequently completed his residency in Urology at McGill University in 2014, receiving the Division of Urology Outstanding Resident/Fellow Teacher of the Year Award in 2014. He is currently in the second year of his fellowship in Andrology at Tulane University, where he also serves as Clinical Instructor of Urology.

Dr. Yafi is a Fellow of the Royal College of Surgeons of Canada (Urology). He has previously served as chairman of the Northeastern Section of the AUA Residents Committee and member of the AUA Residents Committee. He is currently a member of the Sexual Medicine Society of North America Young Clinicians Committee. He has received multiple awards and recognitions, including the first prize essay contest of the Canadian Urological Association. Dr. Yafi has an avid interest in both basic and clinical research, with over 40 peer-reviewed publications and book chapters. His areas of focus include Peyronie’s disease, erectile dysfunction, androgen replacement therapy, prosthetic surgery (inflatable penile prosthesis and artificial urinary sphincter), male infertility, and urethral reconstruction.

 

Pediatric Urology


Janelle Fox

Janelle Fox

MD - United States

Dr. Fox was raised in Southern California and obtained her Bachelor of Arts degree in Business Administration and Bachelor of Science degree in Biology from the University of Redlands in 2001.  She then worked as a clinical and laboratory researcher in Cancer Immunotherapy at Roger Williams Medical Center in Providence, RI until deciding to pursue a medical career.  She received a United States Navy commission in July 2002 at the encouragement of her father, a prior enlisted Navy sailor, then graduated from the University of California San Diego School of Medicine. She completed a Preliminary Surgery Internship then Urology residency at Mayo Clinic in Rochester, MN, then went on to complete a Pediatric Urology fellowship at the Children’s Hospital of Pittsburgh. Following completion of her training in June 2013, Dr. Fox was assigned as a staff Navy urologist to Naval Medical Center Portsmouth where her focus is Pediatric Urology. She has been appointed as Chair of both the Robotic Surgery Committee and Performance Improvement Committee at her institution.  She is actively involved in medical student education for core urology principles, mentorship for the Eastern Virginia Medical School Urology residency, and holds Assistant Professorships at both the Uniformed Services University for Health Sciences and Eastern Virginia Medical School.

Dr. Fox is a board certified urologist and pediatric urologist.  She remains an active member of the Société Internationale d’Urologie and the SIU Academy Pediatric Urology sub-committee, Society of Pediatric Urology, American Association of Clinical Urologists, Society of Government Service Urologists, American Urological Association, Mid-Atlantic Section of the AUA, Tidewater Urological Society and Tidewater Pediatric Society. She is actively involved in International Volunteers in Urology and Children’s Surgery International for Pediatric Urology surgical volunteerism and teaching.  Dr. Fox’s research interests include disorders of sexual development and minimally invasive and robotic surgery in children.

Madina Ndoye

Madina Ndoye

MD - Senegal

Dr Ndoye completed her medical studies at University Cheikh Anta Diop De Dakar in 2006. First rank at the residency admission exam, she spent 5 years training in urology surgery, from 2004 to 2009 under the lead of Pr Serigne Gueye, head of the Department at General Hospital of Grand Yoff. She had done international training as a fellow at France on endourology and incontinence surgery, at Maryland USA NIH/NCI on cancer epidemiology and prevention, and at Pittsburgh / USA on pediatric reconstructive urology surgery. At Senegal, she was the chief of the urology department at Ziguinchor regional Hospital before joining Pr Serigne gueye‘s team as consultant urologist at General Hospital of Grand Yoff. In addition to general urology, her main, clinical activities are oriented on reconstructive urology for kids and adult. As a university assistant, she participates at the academic activities of the department and is author of many publications. She had done many national and international workshops on VVF surgery and training since 2008 as consultant for UNFPA, WAHA, and AMREF. Dr Ndoye is member of many scientific societies as AUA, AORTIC and SIU and did a lot of international conference on urology topic. As a member of AFEMS (Association Of female doctor of Senegal) and ASBEF (Senegalese Association for the welfare Family) member of IPPF (International Planned Parenthood federation planning), she is an active advocate of women’s health and empowerment. She is also an honor Member of LISCA Senegalese League against Cancer. Dr Ndoye has got also a degree in environmental health and global health. She speaks Wolof (native language), French (official language) and English well enough.

Barbara Rampersad

Barbara Rampersad

MBBS, FRCS, FRCS (Paed Surg) - Trinidad and Tobago

Dr. Rampersad is a Paediatric Surgeon/Paediatric Urologist practicing in Trinidad and Tobago. She completed her postgraduate training in the UK in 2004 at AlderHey and Manchester Children's Hospital and also a fellowships at Westmead Children's Hospital in Sydney and Helsinki Children's hospital in Finland.

She is the only Paediatric Urologist for the island of Trinidad and Tobago with a population of 1.4 million, so I see a variety of conditions. She is also a lecturer with the University of the West Indies and she aims is to train upcoming surgeons in Paediatric Urology.

Francis Schneck

Francis Schneck

MD - United States

Coming Soon

David Vandersteen

David Vandersteen

MD - United States

Coming Soon

 

Prostate/Metastatic Cancer


Brian Chapin

Brian Chapin

MD - United States

Dr. Brian Chapin is an Assistant Professor in the Department of Urology at The University of Texas MD Anderson Cancer Center.  He provides complete surgical care for men and women diagnosed with urologic malignancies. He performs open surgery and minimally invasive/robotic surgery, for patients with prostate, kidney, bladder and testis cancers.  His major clinical focus is on the treatment of high risk- localized, locally advanced and metastatic prostate cancers. He has active clinical research protocols developing the integration of surgical, radiation and medical therapies in the treatment of advanced prostate cancer.  Dr. Chapin is involved with the basic science/translational research program at M.D Anderson, which is attempting to identify the immunologic changes that occur with surgical and systemic therapy treatments in advanced prostate cancer and how these changes may be exploited with use of newer immune modulating therapies.  Using a comprehensive multimodality approach to this disease, Dr. Chapin’s goal is to ease suffering and prolong survival in men with advanced prostate cancer.      

Pilar Laguna

Pilar Laguna

MD - The Netherlands

Dr Pilar Laguna completed her medical training at the Autonomous University of Barcelona, Spain, in 1979. After completing her training in urology, she joined the medical staff at Hospital del Sagrado Corazon, and later at the Fundacion Puigvert, in Barcelona. She was appointed Chairman of the Hospital Gral La Mancha Centro in Alcazar de San Juan in 1995. In 2000, Dr Laguna moved to the Netherlands, and is currently a member of the medical staff of the Department of Urology at the AMC University Hospital in Amsterdam.

 

Dr Laguna is a committee member of the International Consultation on Stone Disease, supported by the World Health Organization (WHO). She is a past Chairman and current member of the European Association of Urology (EAU) Guidelines Committee on testicular cancer, and is Chairperson of the Ablative Working Party of the EAU Section of Uro-Technology (ESUT). Dr Laguna’s primary filed of interest is renal cancer, and she is one of the pioneers of renal cryosurgery in Europe. She is also Chairperson of the Global Renal Mass study being conducted by the Clinical Research Office of the Endourological Society (CROES), and is a member of the Société International d’Urologie’s (SIU’s) SIU Academy team of experts.

 

In additional to the SIU, Dr Laguna is a member of several other urological societies, including the American Urological Association (AUA), the EAU, and the Endourological Society. She is also on the editorial boards of the Journal of Endourology, European Urology, the Journal of Urology, and the BJU International.

 

Dr Laguna has published over 200 peer-reviewed articles in the field of urology, with special focus on minimally invasive therapy, oncological urology, and endourology. She has also co-authored a book on testicular cancer, and has published over 20 book chapters.

Dr. Pilar Laguna is Professor of Uro-oncology, department of Urology at the AMC, University of Amsterdam, the Netherlands. She completed her studies in medicine and training as a urologist at the University of Barcelona. In Spain, she was a staff member of the famous Fundación Puigvert hospital and in 1995 was Chief of the Urology Department in Hospital Gral La Mancha-centro. Since 2002, Dr. Laguna has been a staff member in the Department of Urology AMC, Amsterdam, is an active member of EAU and AUA, and a member of the testis cancer EAU Guidelines panel.

Art Rastinehad

Art Rastinehad

DO - United States

Art Rastinehad, D.O. joined the faculty at Mount Sinai as Associate Professor of Radiology and Urology.  He trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. He has expertise in a wide array of interventional radiological and surgical techniques, including image guided procedures, laparoscopic and robotic surgery. 

Dr. Rastinehad’s prostate cancer team has now incorporated state-of-the-art imaging to help visualize suspicious areas in the prostate for cancer. Dr. Rastinehad has also authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer. Most recently, he is the principle investigator for a Phase III clinical trial using MRI/Ultrasound fusion technology to improve prostate biopsy techniques.  Using information from the prostate MRI, we can now target specific areas to better diagnose and quantify a patient’s prostate cancer. This was the first trial of this technology in the United States outside the National Institutes of Health. This new clinical approach is helping to lay a foundation for the evaluation of a new technique, Focal Therapy, which only treats the diseased portion of the prostate.  As of May 216, Dr Rastinehad was the first in the world to perform a gold nano-particle directed ablation using an transperineal MR US Fusion guided focal therapy system.

For more information, please visit www.interventionalurology.com

Dr. Rastinehad’s research has been published in leading national and international medical journals including The Journal of Urology, Journal of Radiology, Urology, and The British Journal of Urology. He has also authored several book chapters. He has also served as the course director for the first international course on MR US fusion guided prostate biopsies sponsored by the American Urological Association. 

Tilman Todenhöfer

Tilman Todenhöfer

MD - Germany

Tilman Todenhöfer is a urologist at the department of Urology of the Eberhard-Karls-University Tuebingen, Germany (Chairman: A. Stenzl). He has completed a postdoctoral research fellowship at the Vancouver Prostate Centre, Canada. His main fields of interest are circulating biomarkers in advanced prostate and bladder cancer, urine markers for detection of bladder cancer and the inhibition of metabolic pathways for treatment of advanced urothelial carcinoma. He has published more than 80 articles and has received various awards including the Alken Prize, the John-Blandy Prize, the CUA/CUOG research award and the German prostate cancer research award

John Ward

John Ward

MD - United States

Dr. Ward’s major clinical focus is on the treatment of Prostate Cancer at the two extremes of the disease profile.  This clinical focus synergizes with his research focus where he has been a pivotal thought leader in advancement of prostate ablative therapy in particular, subtotal or focal therapy for prostate cancer, prostate cancer imaging techniques, and ablative therapies.  His expertise in cryoablation techniques is recognized world wide as evidenced by the numerous invited lectures and surgical demonstration of the cryoablation operation from China to Brazil.  He is the author or numerous papers on prostate cryoablation and prostate focal therapy.  His recent advancements in prostate cancer imaging through the use of MRI / Ultrasound fusion techniques also uniquely qualifies him for this project which melds therapy with imaging.

Michael Williams

Michael Williams

MD - United States

Coming Soon

 

Renal Cancer


Joseph Ischia

Joseph Ischia

MD - Australia

Dr. Joseph Ischia is a urologist with a special interest in urologic oncology. He completed a two- year clinical and research post-doctoral uro-oncology fellowship at the Vancouver Prostate Centre in Vancouver, Canada.  In Vancouver, he performed research focusing on targeting the insulin-like growth factor binding proteins with a novel antisense in the treatment of advanced castration- and enzalutamide- resistant prostate cancer with Professor Martin Gleave.  Joseph graduated medicine from Melbourne University in 1998 where he also completed his PHD (2012) investigating the role of a neuroendocrine growth factor (gastrin-releasing peptide) and its precursor in the growth of renal cell cancer.  As well as his clinical duties, he continues to be heavily involved in research at The University of Melbourne, Austin Hospital where he is currently studying the protective role of zinc in renal ischaemia and prostate cancer progression.

Jose Karam

Jose Karam

MD, FACS - United States

Dr. Karam is an Assistant Professor of Urology at MD Anderson Cancer Center. He is certified by the American Board of Urology, and provides surgical care for patients with renal, testicular and adrenal tumors. He performs open, laparoscopic, and robotic surgery, with a special interest in surgery for locally advanced and locally recurrent disease.

Dr. Karam earned his medical degree with Distinction from the American University of Beirut. He completed Urology residency at UT Southwestern Medical Center, followed by a Urologic Oncology Fellowship at MD Anderson Cancer Center.

Dr. Karam’s primary clinical and research interest is renal cell carcinoma. He has authored more than 130 articles in urologic oncology. He serves as a reviewer for over 20 journals, and is an Editorial Board member of BJU International, Associate Section Editor for Annals of Surgical Oncology, Section Editor for BMC Urology, and Associate Editor for Frontiers in Oncology.

Dr. Karam is fluent in English, Spanish, Arabic and French and presents in these languages as needed.

Tobias Klatte

Tobias Klatte

MD - Austria

Tobias Klatte is associate professor of urology at the Medical University of Vienna, Austria. He obtained his medical and doctoral degree at the University of Magdeburg (Germany). He completed a research fellowship in urologic oncology at the University of California-Los Angeles before starting clinical training at the Medical University of Vienna. He is now a faculty member of the department. His main clinical interests are surgical oncology and endourology. His research is focused on kidney cancer and bladder cancer. In 2012, he completed his habilitation on prognostic factors in renal cell carcinoma. He has been recognized for his research activities by national and international awards.

Steve Rigs

Steve Rigs

MD - United States

Dr. Steve Riggs is currently an Associate Professor within the Division of Urology, Surgical Care Division and Levine Cancer Institute in Charlotte, N.C. He completed his Oncology fellowship in 2008 at the University of California Los Angles Medical Center. Following this he accepted an appointment to the Department of Urology, Eastern Virginia Medical Center before relocating to Charlotte. He has an active clinical practice in Urologic Oncology that includes a strong interest in writing and conducting clinical trials. He also has an avid interest in clinical and collaborative translational research. He is director of the institutes’ Cancer conferences, Urologic Oncology fellowship and site director for the Urology resident training that occurs in Charlotte. He has authored or co-authored multiple peer-reviewed manuscripts, editorials and invited articles in addition to serving in local and national leadership roles within the field of Urologic Oncology.

 

Transitional Urology


Erin McNamara

Erin McNamara

MD, MPH - United States

Dan Wood

Dan Wood

PhD FRCS(Urol) - United Kingdom

Mr Dan Wood is a Consultant in Adolescent and Reconstructive Urology at University College London Hospitals. He earned his PhD from St Bartholomew’s Hospital Medical School in 1994.

Dan’s principle surgical interest is in major lower urinary tract function and reconstruction in adolescence, particularly with congenital anomalies. He performs major surgical reconstruction for patients with conditions such as bladder exstrophy, disorders of sex development, and spina bifida. He has expertise in augmentation and substitution cystoplasty, ileal conduit, mitrofanoff channels and genitoplasty, including vaginal reconstruction.

Dan did his research and gained his PhD in 2003 with Professor Chris Fry at UCL, looking at cultured bladder cells and their physiology. He continues to maintain a research interest in cell culture and its application, as well as long- term outcomes in adolescent urology.

He is the clinical lead for paediatric surgery and the acute surgical unit, Editor of the Journal of Paediatric Urology, Chairman of the newly formed Congenital Lifelong Urology Working Group in Europe, Patron of the Mitrofanoff Support Charity and a Trustee of the St Peter’s Trust. He is an alumnus of the NHS Staff College Leadership training programme.

Hadley Wood

Hadley Wood

MD - United States

Dr. Wood has been a staff urologist at the Cleveland Clinic since 2009 and currently is Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.  She received her undergraduate degree from Duke University and Doctor of Medicine in 2003 from Johns Hopkins University School of Medicine.  After training at the Cleveland Clinic Glickman Urological and Kidney Institute, she joined the faculty and is currently a member of the Center for Genitourinary Reconstruction.  She has done basic science research at the Institute for Molecular Medicine in Oxford, England and the Lerner Research Institute at Cleveland Clinic.  Her area of subspecialty is genitourinary reconstruction with a focus on adolescents and adults with urological congenital defects.  These include older patients with exstrophy spectrum, cloacal anomalies, hypospadias, myelomeningocele, among others.  In addition, she cares for adolescents and adults with congenital neurological disorders that have resulted in urological problems, like muscular dystrophy and cerebral palsy. She has developed a multidisciplinary clinic for adults with spina bifida at Cleveland Clinic and serves as an adult specialty advisor to the Transition Services Group of the CC Children’s Hospital.

In addition to full time clinical responsibilities and resident teaching, Dr. Wood has been continuously involved in clinical research and her work has been published in a number of peer reviewed journals.  She serves as section editor for Urology (Congenitalism) and as a peer reviewer for many other journals.  She has written 9 book chapters related to her specialty areas, and has co-edited a textbook on Urological Congenitalism (2015, 2016). She is physician lead for the the AUA Working Group for Urological Congenitalism and on the Physician Advisory Group of the Spina Bifida Association (2015, 2016). She has been an active member of several societies, including the AUA, Society of Genitourinary Reconstructive Surgeons, Society of Urodynamics and Female Urology, American College of Surgeons, Society of Women In Urology, Cleveland Clinic Women’s Professional Staff Association, Ohio Urological Association, and Alpha Omega Alpha.  Dr. Wood is involved in mentoring and developing resources for women urologists and surgeons within her institution and nationally and serves as founding co-chair of the Northeast Ohio Women In Surgery Group and as president as the Women’s Professional Staff Association at the Cleveland Clinic.

 

Trauma and Reconstruction


Benjamin Breyer

Benjamin Breyer

MD - United States

Dr. Breyer graduated from the University of Chicago Pritzker School of Medicine. He attended residency at the University of California San Francisco.  Breyer completed a fellowship in complex male genitourinary reconstruction and trauma surgery under the direction, of Jack W. McAninch, MD.  Breyer was invited to join the faculty in 2011. In 2014, he was named Chief of Urology, San Francisco General Hospital.

Breyer’s clinical interests include complex urethral and penile reconstruction, male incontinence, male fistula, surgical treatment for erectile dysfunction, and transgender surgery. He is expert in both minimally invasive and complex open reconstructive surgery.

Breyer’s primary research interests involve studying the epidemiology of sexual dysfunction, lower urinary tract symptoms, and trauma and reconstruction.   He is NIH supported and has authored or coauthored over 150 articles and book chapters. Breyer is a member of the Trauma and Urinary Reconstructive Network of Surgeons (TURNS - http://turnsresearch.org).

Dmitriy Nikolavsky

Dmitriy Nikolavsky

MD - United States

Dr. Dmitriy Nikolavsky earned his medical degree from Wayne State University School of Medicine in 2005 after completing his Bachelor’s degree in Biochemistry at University of Detroit Mercy in 2000.  He completed his internship in General Surgery in 2007 and subsequently his residency in Urology in 2011, both at William Beaumont Hospital in Royal Oak, Michigan.  He went on to train at the University of Colorado as a fellow in genitourinary reconstruction in 2011. He then joined the faculty at SUNY Upstate Medical University in Syracuse, NY with an appointment as Assistant Professor in Urology and Director of Reconstructive Urology in 2012. 

Dr. Nikolavsky runs a busy practice that focuses on reconstructive urology. His clinical interests include urethral reconstruction, fistula, male incontinence and correction of complications of transgender surgery. He holds a wide array of research interests, encompassing both clinical and patient-reported outcomes of urologic reconstruction, and development of novel techniques for urethral and ureteral reconstruction. He is working in collaboration with several centers in the US and worldwide on projects ranging from bench research to clinical outcomes studies.

Dr. Nikolavsky is a member of the Societe Internationale d’Urologie (SIU), American Urological Association (AUA), Society of Genitourinary Reconstructive Surgeons (GURS) and International Russian-speaking Urological Society (iRUS). Since 2012, he has served as the Program Director/AUA Liaison for the Russian Language Session at the AUA annual meeting.

Arabind Panda

Arabind Panda

MS, MCh - India

Dr. Panda is Associate Professor of Urology at the Christian Medical College hospital, Vellore, India. He completed his Urological training in 2009 and has been focusing mainly on reconstructive urology and genitourinary trauma.

He has been an associate editor of the Indian Journal of Urology  for the past 5 years. He is particularly interested in reconstructive surgery of the urethra, both male and female; particularly in difficult posterior urethroplasty apart from vesicovaginal and rectourethral fistulas. He was awarded the 2014 AUA/IAUA Chakrobortty fellowship  by the American Urological Association and the 2013 the Klinikum Luneburg German Fellowship 2013.

He is closely involved in mentorship and training of urological residents and has more than 13 publications.

Jack Zuckerman

Jack Zuckerman

MD - United States

Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed an internship in General Surgery at the Naval Medical Center in San Diego and then went on to complete Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He finished his training at EVMS with a fellowship in genitourinary reconstructive surgery.  He recently returned to California and is faculty at the Naval Medical Center in San Diego.

 Dr. Zuckerman’’s research interests are primarily focused on male reconstruction, including ongoing prospective randomized controlled trials, basic science animal models and large clinical databases.  While his focus is on urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology.

 

Uro-technology


François Audenet

François Audenet

MD - France

Francois Audenet, MD, is a full-time assistant in the Urology Department at Hôpital Européen Georges Pompidou, in Paris, France. Dr. Audenet received his medical degree from Université Pierre et Marie Curie – Faculté de Médecine in Paris and completed his education with General Surgery and Urology at Paris University Hospitals, where he performed training residencies. After obtaining a Master’s Degree in Surgical Science (2011) and the completion of his surgical training in 2012, he has been granted with the Gold Medal in Surgery, awarding each year the best resident enrolled in the surgical program of Paris University Hospitals. He had the opportunity to complete a fellowship training in minimally invasive surgery and Urologic Oncology at Institut Mutualiste Montsouris in Paris. In November 2013, he has been enrolled as a full-time assistant in the Department of Urology and Transplant Surgery at Hôpital Européen Georges Pompidou, in Paris. In July 2016, he started a Fellowship training in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York, USA.

Dr Audenet is mostly dedicated to urological oncology and minimally invasive surgical techniques, performing clinical, research and teaching duties at his Institution. He has published more than 60 peer reviewed research papers and reviews paper submissions for several urological journals. His research is mainly focused on oncology and particularly onco-genetics in renal cell carcinoma and urothelial carcinoma.

Maurice Garcia

Maurice Garcia

MD - United States

Maurice M. Garcia, M.D., MAS is a Urologic surgeon who specializes in transgender and reconstructive Genital surgery, sexual medicine, and neurourology. He completed his urologic residency training at University of California San Francisco, and additional fellowship training in London at University College London and St. Peters Urology, in London, UK. Dr. Garcia is Assistant Professor of Urology at University of California San Francisco School of Medicine and hospitals.  

Alexandre Ingels

Alexandre Ingels

MD - France

Dr. Alexandre Ingels is a fellowship-trained urologist with a main interest in uro-oncology and more specifically in renal cell carcinoma. He completed his basic training at the University Hospital System of Paris and post-doctoral training in basic research at Stanford University. He continued as a fellow in uro-oncology at AMC, Amsterdam and another two years as “chef de clinique” (Assistant Professor) at Kremlin-Bicêtre Hospital focusing on uro-oncology and transplantation. He is currently a PhD candidate at Paris Sud University, working on molecular imaging in renal cell carcinoma at the Institut Gustave Roussy laboratory.

As a clinician, he developed an expertise in major uro-oncology surgeries for renal, bladder and prostate cancer. As a researcher he has over 15 peer-reviewed publications. He obtained a master in public health (2010) and a MS in biology (2012) with a focus on renal cell carcinoma, participating in the development of an in-vivo model of renal cell carcinoma and its development for pre-clinical drug explorations.

Based on his prior works, he continues his research with patient-derived-xenograft models to assess new techniques of molecular ultrasound imaging in order to predict renal tumor agressivity and response to targeted therapies. He recently joined the Department of Urology at the Institut Mutualiste Montsouris in Paris, France as a Senior surgeon.

Rafael Sanchez-Salas

Rafael Sanchez-Salas

MD - France

Dr. Rafael Sanchez-Salas is a urological surgeon at the Institut Mutualiste Montsouris in Paris, France.  He received his medical degree from the Universidad de los Andes (ULA) in Mérida, Venezuela, followed by general surgery and urological training at the Hospital Universitario de Caracas, also in Venezuela.

After basic training, Dr. Sanchez-Salas undertook research and clinical fellowship training in urological oncology and minimally invasive urological surgery at Memorial Sloan-Kettering Cancer Center in the United States, Clínica Santa María in Chile, and the Institut Mutualiste Montsouris in France, where he eventually earned his spot as staff surgeon.

In addition to surgical work, Dr. Sanchez-Salas is an active academic urologist with international publications and ongoing collaborations in the field of urological oncology and minimally invasive surgery. He runs the Medical Education Office for the Confederación Americana de Urología (CAU), and he has recently been inducted to the Board of the European Robotic Urological Society (ERUS).

Fernando Secin

Fernando Secin

MD, PHD - Argentina

Fernando P. Secin, MD, PhD, is a Urologist Oncologist trained at Memorial Sloan Kettering Cancer Center, NY, USA. He currently works at CEMIC University Hospital and San Lazaro Foundation in Buenos Aires, Argentina. Dr. Secin is an Assistant Professor of Urology at the University of Buenos Aires School of Medicine and at CEMIC University Hospital

Arjun Sivaraman

Arjun Sivaraman

MD - United States

Dr. Arjun Sivaraman completed his medical school and urology residency in India and is being fellowship trained in Advanced laparoscopy, Robotic surgery and Focal therapy at L’Institut Mutualiste Montsouris, Paris, France. His career pathway is towards being a Urologic Oncologist and is selected for a clinical and research training program focused on urologic cancers at Memorial Sloan Kettering Cancer Center.

Dr. Arjun Sivaraman’s main clinical activities involves Minimally Invasive Surgical management of urological malignancies and Focal therapy for prostate cancer. Apart from his active clinical activities, Dr. Arjun Sivaraman is also involved in research programs to improve the care of patients with urologic cancers. His research interests are in Prostate biopsy techniques, Prostate imaging and Focal therapy for prostate cancer.

As a recognition of his academic merits, Dr. Arjun Sivaraman have received several national and international awards and also have several publications in international peer reviewed journals. He received the highly reputed European Urology Scholarship Program (EUSP) grant from European Association of Urology (EAU) to evaluate the methods to improve the functional outcomes of Robotic Radical Prostatectomy.

Dr. Arjun Sivaraman is also an active member of international urological associations and have presented his work in several urologic congresses. He is a part of the Société Internationale d'Urologie (SIU) -  Urotechnology sub-committee to develop e-learning portal which is aimed at providing urologists and healthcare providers with a convenient, dynamic, and innovative educational tool.

Samuel Yee

Samuel Yee

MD - China

Dr. Samuel CH Yee graduated from The University of Hong Kong. He held fellowships from the Royal College of Surgeon of Edinburgh and the College of Surgeons of Hong Kong, and has been with Prince of Wales Hospital, the Chinese University of Hong Kong since 2006.

 Dr. Yee completed the Advanced Clinical Fellowship in Laparoscopy and Robotic Urology at the Institut Mutualiste Montsouris, Paris. Besides being a proficient urological surgeon, he is actively involved in clinical research. His interests in urology include urological oncology and voiding dysfunction. He currently holds the positions of Associate Consultant at the Prince of Wales Hospital as well as Honorary Clinical Assistant Professor for the Chinese University of Hong Kong.